Matches in Wikidata for { <http://www.wikidata.org/entity/Q88505547> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- Q88505547 description "artículu científicu espublizáu en marzu de 2018" @default.
- Q88505547 description "scientific article published on 13 March 2018" @default.
- Q88505547 description "wetenschappelijk artikel" @default.
- Q88505547 description "наукова стаття, опублікована 13 березня 2018" @default.
- Q88505547 name "Beneficial effects of anti-EGFR agents, Cetuximab or Nimotuzumab, in combination with concurrent chemoradiotherapy in advanced nasopharyngeal carcinoma" @default.
- Q88505547 name "Beneficial effects of anti-EGFR agents, Cetuximab or Nimotuzumab, in combination with concurrent chemoradiotherapy in advanced nasopharyngeal carcinoma" @default.
- Q88505547 type Item @default.
- Q88505547 label "Beneficial effects of anti-EGFR agents, Cetuximab or Nimotuzumab, in combination with concurrent chemoradiotherapy in advanced nasopharyngeal carcinoma" @default.
- Q88505547 label "Beneficial effects of anti-EGFR agents, Cetuximab or Nimotuzumab, in combination with concurrent chemoradiotherapy in advanced nasopharyngeal carcinoma" @default.
- Q88505547 prefLabel "Beneficial effects of anti-EGFR agents, Cetuximab or Nimotuzumab, in combination with concurrent chemoradiotherapy in advanced nasopharyngeal carcinoma" @default.
- Q88505547 prefLabel "Beneficial effects of anti-EGFR agents, Cetuximab or Nimotuzumab, in combination with concurrent chemoradiotherapy in advanced nasopharyngeal carcinoma" @default.
- Q88505547 P1433 Q88505547-CAF837E0-AD40-4EB1-B9A8-2962FBE403EF @default.
- Q88505547 P1476 Q88505547-D3B3AF10-5D69-49B3-A36C-C9805D5FD210 @default.
- Q88505547 P2093 Q88505547-1D3674F5-0033-4185-8A73-E5FA55759C26 @default.
- Q88505547 P2093 Q88505547-23034F06-D790-46B1-B6CC-39CFFB2C4997 @default.
- Q88505547 P2093 Q88505547-27E3EC71-1758-448F-8746-50F23CCBE13C @default.
- Q88505547 P2093 Q88505547-3197726D-167A-46E5-8BAA-ACD8F0170C45 @default.
- Q88505547 P2093 Q88505547-3CF5E182-B4B4-4048-B3EE-B9628E5FF0EE @default.
- Q88505547 P2093 Q88505547-4458A707-6C56-41F1-8129-DC1CC4856C69 @default.
- Q88505547 P2093 Q88505547-46CFDDBA-497A-4B99-9325-E675BBD2778C @default.
- Q88505547 P2093 Q88505547-53695BB4-D566-45E0-A82B-23D4C3E66C88 @default.
- Q88505547 P2093 Q88505547-563BA4CD-922A-4A17-8264-10E96BD419E2 @default.
- Q88505547 P2093 Q88505547-5D00F446-95D3-4063-A5FF-A131CB6E5E2E @default.
- Q88505547 P2093 Q88505547-78A2910D-C437-472A-8078-9EC5B08B2BBB @default.
- Q88505547 P2093 Q88505547-9300FED6-E889-41E2-B611-9BED38ACB09F @default.
- Q88505547 P2093 Q88505547-964BF4C4-1202-468B-B76E-36D97F304ABB @default.
- Q88505547 P2093 Q88505547-970D1DDA-5DC1-47AE-B16B-E755AF58E90A @default.
- Q88505547 P2093 Q88505547-98E6E0AA-3BA0-475E-9BF1-DF2841B7DD4B @default.
- Q88505547 P2093 Q88505547-C34E9F9C-DDA8-47B3-AFFE-D1255546E023 @default.
- Q88505547 P2093 Q88505547-C545E839-9DB8-4004-AA6B-D34BF4755F9C @default.
- Q88505547 P2093 Q88505547-D3E6C095-DD55-4EDB-9085-D48F6AB9D51E @default.
- Q88505547 P2093 Q88505547-ECF0802D-4AD3-42DE-857E-709427EACE47 @default.
- Q88505547 P2093 Q88505547-FA072D02-EDF9-4C6E-9BB9-A97B284AF5CE @default.
- Q88505547 P304 Q88505547-D93B1953-CD95-4E4F-B21F-685F247570E0 @default.
- Q88505547 P31 Q88505547-30629E0A-6B01-4D95-97D8-77CF59DBDC7D @default.
- Q88505547 P356 Q88505547-823FD6D6-49EC-4371-B7C0-363E37F636F8 @default.
- Q88505547 P478 Q88505547-032F8DFA-680A-473E-A1A6-492F1E2BD471 @default.
- Q88505547 P577 Q88505547-A439D9D4-287C-4CDB-8C5D-26EB67DD67FB @default.
- Q88505547 P698 Q88505547-79789905-9FF4-4893-BE64-85256A90A4C8 @default.
- Q88505547 P921 Q88505547-E75D2A67-87D3-403C-8D3A-425EBBFE2AA2 @default.
- Q88505547 P356 J.ORALONCOLOGY.2018.03.002 @default.
- Q88505547 P698 29706183 @default.
- Q88505547 P1433 Q7099367 @default.
- Q88505547 P1476 "Beneficial effects of anti-EGFR agents, Cetuximab or Nimotuzumab, in combination with concurrent chemoradiotherapy in advanced nasopharyngeal carcinoma" @default.
- Q88505547 P2093 "Ai-Hua Lin" @default.
- Q88505547 P2093 "Chao-Feng Li" @default.
- Q88505547 P2093 "Chao-Nan Qian" @default.
- Q88505547 P2093 "Hai-Qiang Mai" @default.
- Q88505547 P2093 "Hao-Jiong Zhang" @default.
- Q88505547 P2093 "Hao-Yuan Mo" @default.
- Q88505547 P2093 "Ji-Bin Li" @default.
- Q88505547 P2093 "Jing-Yu Cao" @default.
- Q88505547 P2093 "Jun Ma" @default.
- Q88505547 P2093 "Ling Guo" @default.
- Q88505547 P2093 "Mei Lin" @default.
- Q88505547 P2093 "Ming-Yuan Chen" @default.
- Q88505547 P2093 "Qi Yang" @default.
- Q88505547 P2093 "Rui You" @default.
- Q88505547 P2093 "Tao Yu" @default.
- Q88505547 P2093 "Xiong Zou" @default.
- Q88505547 P2093 "Yi-Jun Hua" @default.
- Q88505547 P2093 "Yi-Nuan Zhang" @default.
- Q88505547 P2093 "Ying Sun" @default.
- Q88505547 P2093 "You-Ping Liu" @default.
- Q88505547 P304 "1-8" @default.
- Q88505547 P31 Q13442814 @default.
- Q88505547 P356 "10.1016/J.ORALONCOLOGY.2018.03.002" @default.
- Q88505547 P478 "80" @default.
- Q88505547 P577 "2018-03-13T00:00:00Z" @default.
- Q88505547 P698 "29706183" @default.
- Q88505547 P921 Q420296 @default.